Results 11 to 20 of about 1,844 (152)

Efficacy and Recovery of Remimazolam Versus Midazolam in Sedated Colonoscopy: A Multicenter Randomized Controlled Trial in Japan. [PDF]

Dig Endosc
ABSTRACT Objectives Sedation during colonoscopy is becoming increasingly important. Remimazolam, an ultra‐short‐acting benzodiazepine, has a shorter pharmacokinetic half‐life than that of midazolam. This study examined whether remimazolam provides superior sedation during colonoscopy in Japanese patients.
Yamaguchi D, Ichijima R, Ikehara H, Minoda Y, Esaki M, Takamori A, Yoh A, Shirouzu M, Sadashima K, Fujimura Y, Shimamura T, Takedomi H, Akutagawa T, Tsuruoka N, Sakata Y, Wada T, Kusano C, Shimoda R, Esaki M.   +18 more
europepmc   +2 more sources

Real-World Evaluation of Remimazolam for Sedation During Gastrointestinal Endoscopy: Efficacy, Safety, and Risk Factors. [PDF]

JGH Open
ABSTRACT Background and Aim Remimazolam is a benzodiazepine receptor agonist intravenous anesthetic. This study aimed to evaluate the efficacy and safety of remimazolam for sedation during gastrointestinal endoscopy using real‐world clinical data.
Sakurai H, Miyazaki K, Nakayama A, Sasaki M, Oowada M, Sugawara M, Kubo Y, Mizobe R, Katsumi A, Ishizawa M, Imura Y, Murata S, Minezaki D, Iwata K, Tojo A, Masunaga T, Kirita K, Mizutani M, Nishikawa M, Takatori Y, Akimoto T, Kawasaki S, Matsuura N, Tomida H, Sujino T, Takabayashi K, Takanori K, Yahagi N, Kato M.   +28 more
europepmc   +2 more sources

Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single-Center Retrospective Cohort Study. [PDF]

DEN Open
ABSTRACT Objectives Remimazolam is a novel ultra–short‐acting benzodiazepine that may offer advantages over conventional sedatives in endoscopic procedures. Evidence for its use in pancreatobiliary endoscopic ultrasonography (EUS) is limited. We compared the efficacy and safety of remimazolam and midazolam in outpatient pancreatobiliary EUS.
Toyonaga H, Masaki M, Yamazaki H, Oka A, Matsuno Y, Nakata H, Takayama S, Nakagawa T, Takayama T, Orino M, Matsumoto H, Sumimoto K, Takeo M, Fukata N, Yamashina T, Shimatani M, Naganuma M.   +16 more
europepmc   +2 more sources

Comparison of Remimazolam and Midazolam for Sedation During Endoscopic Retrograde Cholangiopancreatography-Related Procedures. [PDF]

DEN Open
ABSTRACT Objectives Remimazolam is an ultra‐short‐acting benzodiazepine recently approved for endoscopic procedures in Japan as a sedative agent. We aimed to compare the efficacy and safety of remimazolam and midazolam for endoscopic retrograde cholangiopancreatography (ERCP)‐related procedures.
Tanisaka Y, Ryozawa S, Ito S, Mizuide M, Fujita A, Watanabe R, Hamamura R, Matsuno Y.   +7 more
europepmc   +2 more sources

The Clinical Reality of Endoscopic Sedation: Balancing Pharmacokinetic Efficiency With Diagnostic Excellence. [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Chen Q, Ni W.
europepmc   +2 more sources

Comparison of Adverse Reactions Between Remimazolam and Propofol in Hysteroscopic Surgery in Mainland China: A Meta-Analysis and Systematic Review. [PDF]

Anesthesiol Res Pract
Background The purpose of this meta‐analysis was to compare the adverse reactions of remimazolam and propofol in hysteroscopic anesthesia and to evaluate the efficacy of remimazolam in alleviating adverse reactions. Methods We conducted a database search using China National Knowledge Infrastructure (CNKI), PubMed, and the Cochrane Library to identify ...
Liu Z, Zhu K, Zhao Z, Zeng Q.
europepmc   +2 more sources

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

Frontiers in Medicine, 2022
ObjectiveHypotension is common in propofol anesthesia. Whether remimazolam could reduce intraoperative hypotension remains unknown. We therefore tested the primary hypothesis that remimazolam reduces the incidence of intraoperative hypotension compared ...
Yuwei Qiu, Yuwei Qiu, Wei Gu, Mingye Zhao, Yunyun Zhang, Jingxiang Wu, Jingxiang Wu   +6 more
doaj   +1 more source

Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study [PDF]

Korean Journal of Anesthesiology
Background Minimalist transcatheter aortic valve replacement (TAVR) under monitored anesthesia care (MAC) emphasizes early recovery. Remimazolam is a novel benzodiazepine with a short recovery time.
Ji-Hyeon Kim, Jae-Sik Nam, Wan-Woo Seo, Kyung-Woon Joung, Ji-Hyun Chin, Wook-Jong Kim, Dae-Kee Choi, In-Cheol Choi   +7 more
doaj   +1 more source

Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report

JA Clinical Reports, 2021
Background Remimazolam has less cardiovascular depressant effects than propofol in non-cardiac surgical patients. However, the efficacy and safety of remimazolam in cardiac surgery with cardiopulmonary bypass (CPB) have not been reported.
Kota Saito, Sho Ohno, Makishi Maeda, Naoyuki Hirata, Michiaki Yamakage   +4 more
doaj   +1 more source

Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report

JA Clinical Reports, 2022
Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis.
Satoshi Uchida, Daiki Takekawa, Eiji Hashiba, Reiko Kudo, Kazuyoshi Hirota   +4 more
doaj   +1 more source